| Robert Chin Jr, MD | |
|
3001 Lyndhurst Ave, Winston Salem, NC 27103-4007 | |
| (336) 765-0383 | |
| (336) 760-6918 |
| Full Name | Robert Chin Jr |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Pulmonary Disease |
| Location | 3001 Lyndhurst Ave, Winston Salem, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053396481 | NPI | - | NPPES |
| 4198 | Other | NC | PARTNERS |
| 197834000 | Medicaid | WV | |
| 5644077 | Other | NC | AETNA |
| 6050646 | Medicaid | VA | |
| 37223 | Other | NC | MEDCOST |
| 22354 | Other | NC | BCBS |
| Q32664 | Medicaid | SC | |
| 8922354 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 32664 (North Carolina) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 32664 (North Carolina) | Primary |
| Entity Name | Wake Forest University Health Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003803032 PECOS PAC ID: 4486564952 Enrollment ID: O20031105000436 |
News Archive
Celldex Therapeutics, Inc. today announced initiation of a Phase 1 study of its therapeutic human antibody candidate, CDX-1127, in patients with selected malignant solid tumors or hematologic cancers.
A set of proteins involved in the body's natural defenses produces a large number of mutations in human DNA, according to a study led by researchers at the National Institutes of Health. The findings suggest that these naturally produced mutations are just as powerful as known cancer-causing agents in producing tumors.
While scientists have known for several years that our body's internal clock helps regulate many biological processes, researchers have found that the reverse is also true: Many common biological processes - including insulin metabolism - regulate the clock, according to a new study by investigators at the University of Pennsylvania School of Medicine, the Genomics Institute of the Novartis Research Foundation, and the University of California at San Diego.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced commencement of operations on the initial phase of production at the Company's Fengxian facility. This new multi-purpose pharmaceutical development and cGMP manufacturing facility is located in Fengxian in the suburbs of Shanghai, China.
A ubiquitin-conjugating enzyme that regulates the cell cycle promotes chromosome missegregation and tumor formation, according to van Ree et al. in the January 11 issue of the Journal of Cell Biology (www.jcb.org).
› Verified 1 days ago
| Entity Name | Spectrum Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801878632 PECOS PAC ID: 1254234388 Enrollment ID: O20040128000275 |
News Archive
Celldex Therapeutics, Inc. today announced initiation of a Phase 1 study of its therapeutic human antibody candidate, CDX-1127, in patients with selected malignant solid tumors or hematologic cancers.
A set of proteins involved in the body's natural defenses produces a large number of mutations in human DNA, according to a study led by researchers at the National Institutes of Health. The findings suggest that these naturally produced mutations are just as powerful as known cancer-causing agents in producing tumors.
While scientists have known for several years that our body's internal clock helps regulate many biological processes, researchers have found that the reverse is also true: Many common biological processes - including insulin metabolism - regulate the clock, according to a new study by investigators at the University of Pennsylvania School of Medicine, the Genomics Institute of the Novartis Research Foundation, and the University of California at San Diego.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced commencement of operations on the initial phase of production at the Company's Fengxian facility. This new multi-purpose pharmaceutical development and cGMP manufacturing facility is located in Fengxian in the suburbs of Shanghai, China.
A ubiquitin-conjugating enzyme that regulates the cell cycle promotes chromosome missegregation and tumor formation, according to van Ree et al. in the January 11 issue of the Journal of Cell Biology (www.jcb.org).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Chin Jr, MD 3001 Lyndhurst Ave, Winston Salem, NC 27103-4007 Ph: (336) 765-0383 | Robert Chin Jr, MD 3001 Lyndhurst Ave, Winston Salem, NC 27103-4007 Ph: (336) 765-0383 |
News Archive
Celldex Therapeutics, Inc. today announced initiation of a Phase 1 study of its therapeutic human antibody candidate, CDX-1127, in patients with selected malignant solid tumors or hematologic cancers.
A set of proteins involved in the body's natural defenses produces a large number of mutations in human DNA, according to a study led by researchers at the National Institutes of Health. The findings suggest that these naturally produced mutations are just as powerful as known cancer-causing agents in producing tumors.
While scientists have known for several years that our body's internal clock helps regulate many biological processes, researchers have found that the reverse is also true: Many common biological processes - including insulin metabolism - regulate the clock, according to a new study by investigators at the University of Pennsylvania School of Medicine, the Genomics Institute of the Novartis Research Foundation, and the University of California at San Diego.
ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced commencement of operations on the initial phase of production at the Company's Fengxian facility. This new multi-purpose pharmaceutical development and cGMP manufacturing facility is located in Fengxian in the suburbs of Shanghai, China.
A ubiquitin-conjugating enzyme that regulates the cell cycle promotes chromosome missegregation and tumor formation, according to van Ree et al. in the January 11 issue of the Journal of Cell Biology (www.jcb.org).
› Verified 1 days ago
Shannon Mitchell St Clair, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 186 Kimel Park Dr, Winston Salem, NC 27103 Phone: 336-277-2000 Fax: 336-277-2050 | |
Dr. Kamal Hanee Henderson, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 186 Kimel Park Dr, Winston Salem, NC 27103 Phone: 336-277-2000 Fax: 336-277-2050 | |
Dr. Michael Joseph Mccormack Jr., M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Medical Center Blvd, Winston Salem, NC 27157 Phone: 336-716-2255 | |
Brooke Williams, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3333 Silas Creek Pkwy, Winston Salem, NC 27103 Phone: 336-718-8383 | |
Dr. David Defeo, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3001 Lyndhurst Ave, Winston Salem, NC 27103 Phone: 336-765-0383 Fax: 336-768-1737 | |
James Alan Senft, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: Medical Center Blvd, Winston Salem, NC 27157 Phone: 336-716-2011 Fax: 336-713-9576 | |
Dr. Michael Richard Morgan, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1381 Westgate Center Dr, Winston Salem, NC 27103 Phone: 336-718-7080 Fax: 336-718-0441 |